Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Repurchased
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares OutstandingShares Repurchased
Ratios

Pharma-Bio Serv (PBSV) Long-Term Debt Repayments (2016 - 2021)

Pharma-Bio Serv filings provide 12 years of Long-Term Debt Repayments readings, the most recent being $64228.0 for Q2 2021.

  • On a quarterly basis, Long-Term Debt Repayments rose 2244.94% to $64228.0 in Q2 2021 year-over-year; TTM through Apr 2022 was $64228.0, a 11.61% decrease, with the full-year FY2020 number at $11030.0, down 83.7% from a year prior.
  • Long-Term Debt Repayments hit $64228.0 in Q2 2021 for Pharma-Bio Serv, up from $2851.0 in the prior quarter.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $64228.0 in Q2 2021 to a low of $2631.0 in Q3 2019.
  • Median Long-Term Debt Repayments over the past 5 years was $3306.5 (2018), compared with a mean of $11967.9.
  • Biggest five-year swings in Long-Term Debt Repayments: tumbled 95.36% in 2020 and later skyrocketed 2244.94% in 2021.
  • Pharma-Bio Serv's Long-Term Debt Repayments stood at $3263.0 in 2017, then increased by 22.25% to $3989.0 in 2018, then tumbled by 33.19% to $2665.0 in 2019, then increased by 5.55% to $2813.0 in 2020, then soared by 2183.26% to $64228.0 in 2021.
  • The last three reported values for Long-Term Debt Repayments were $64228.0 (Q2 2021), $2851.0 (Q1 2021), and $2813.0 (Q4 2020) per Business Quant data.